[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Riaz, 2016 - Google Patents

Evaluation of signalling and phosphorylation responses of the human histamine H₄ receptor (H₄R) and the human free fatty acid receptor 4 (FFA4)

Riaz, 2016

View PDF
Document ID
3884335929393685902
Author
Riaz S
Publication year

External Links

Snippet

The knowledge that G protein-coupled receptors (GPCRs) are regulated by phosphorylation in a process that results in the recruitment of arrestins, leading to receptor desensitisation is now well known. The histamine H₄ receptor (H₄R) and the free fatty acid receptor 4 (FFA4) …
Continue reading at figshare.le.ac.uk (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups

Similar Documents

Publication Publication Date Title
Pierce et al. Classical and new roles of β-arrestins in the regulation of G-protein-coupled receptors
Luttrell et al. Beyond desensitization: physiological relevance of arrestin-dependent signaling
Fraser et al. A novel lipid‐anchored A‐kinase Anchoring Protein facilitates cAMP‐responsive membrane events
US7083933B1 (en) Methods for identification of modulators of OSGPR116 activity
US20030096299A1 (en) Natural ligand of G protein coupled receptor ChemR23 and uses thereof
US20120208843A1 (en) Method of Using GPR35 to Identify Metabolic-Stabilizing Compounds
JP2010515882A (en) G protein-coupled receptor and modulators thereof for treating GABA-related neurological disorders including sleep-related disorders
TW200539867A (en) Human g protein-coupled receptor and modulators thereof for the treatment of hyperglycemia and related disorders
Chilmonczyk et al. Ligand-directed trafficking of receptor stimulus
Riaz Evaluation of signalling and phosphorylation responses of the human histamine H₄ receptor (H₄R) and the human free fatty acid receptor 4 (FFA4)
JP2004033211A (en) Receptor of neuropeptide and use of the same
JPWO2005075641A1 (en) Screening method
JP2009539362A (en) G protein-coupled receptor 39 (GPR39)
EP1692171B1 (en) Agents modulating the activity of ccrl2 and methods of using the same
WO2006109855A1 (en) Peptide having food intake stimulating effect and method for screening for the peptide
TWI338046B (en) Human g protein-coupled receptor and modulators thereof for the treatment of inflammatory disorders
WO2005121356A1 (en) Novel screening method
CA2463553A1 (en) Gastrointestinal chemosensory receptors
AU2006241928B2 (en) Peptide having anti-anxiety effect and method for screening thereof
US7879566B2 (en) Methods for the identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease
WO2000031107A1 (en) 7tm receptor hlwar77
Mahmud Defining ligand binding modes of the orphan G protein-coupled receptor GPR84
Alhosaini Signalling, desensitization and resensitization of neuromedin U receptors
小山亮吉 et al. Pharmacological Characterization of Drug Candidates Targeting Receptors
US20090029406A1 (en) Npy Y4 Agonist as Therapeutic Agent for Disease Accompanied by Intestinal Tract Dysfunction